AJU-C52

· AJU Pharm Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AJU-C52, covering 2024-05-22 to 2024-05-22. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of AJU-C52 in Essential Hypertension Patients [Phase 3]